chuminhua2019-10-23 23:33
10/22,Trovagene公$Trovagene(TROV)$ 宣布,其在研PLK1抑制剂onvansertib(PCM-075),与Folfiri,Avastin(bevacizumab)联合,作为二线疗法在治疗携带KRAS基因突变的转移性结直肠癌(CRC)患者的1b/2期临床试验中,取得积极的试验初期数据。在第一批患者的分析中,观察到肿瘤KRAS基因突变负荷水...查看全文
牛唐2019-08-21 14:21
$Ardelyx(ARDX)$ $Trovagene(TROV)$ 放量上涨的runup走势,9月13号,ARDX的药物Ibresla在IBS适应症方面会有审批,9月底前计划公布高磷酸盐血症方面的三期topline data;trov是在8月24日计划公布 Onvansertib 与Zytiga的二期数据$复星医药(SH600196)$查看全文
越炒股越美2019-04-25 14:53
【汇众医疗】4月23日医药股盘点:6支生物制药股势头强劲,上涨幅度均高于15%
$Atossa Genetics(ATOS)$$Trovagene(TROV)$ $Athersys(ATHX)$ 4月23日股市收盘时,6支生物制药公司股票上涨,涨幅均高于15%。而研发乳腺癌药物的Atossa Genetics以3.48美元收盘,上涨22.97%,涨幅最大。研究罕见病药...查看全文
$Trovagene(TROV)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001104659-19-062057 Act: 33 Size: 367 KB 网页链接
$Trovagene(TROV)$ S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933 Filed: 2019-11-08 AccNo: 0001104659-19-061562 Size: 62 KB 网页链接
$Trovagene(TROV)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-11-07 AccNo: 0001628280-19-013646 Size: 5 MB 网页链接
$Trovagene(TROV)$ 8-K - Current report Filed: 2019-11-07 AccNo: 0001628280-19-013668 Size: 230 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Trovagene(TROV)$ 8-K - Current report Filed: 2019-11-06 AccNo: 0001628280-19-013431 Size: 64 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Trovagene(TROV)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-11-04 AccNo: 0001104659-19-059098 Size: 127 KB 网页链接
$Trovagene(TROV)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-11-01 AccNo: 0000919574-19-006673 Size: 114 KB 网页链接
$Trovagene(TROV)$ S-1 - General form for registration of securities under the Securities Act of 1933 Filed: 2019-11-01 AccNo: 0001104659-19-058988 Size: 392 KB 网页链接
$Trovagene(TROV)$ D - Notice of Exempt Offering of Securities Filed: 2019-10-30 AccNo: 0001209191-19-054520 Size: 11 KB 网页链接
$Trovagene(TROV)$ 8-K - Current report Filed: 2019-10-28 AccNo: 0001193125-19-276277 Size: 483 KBItem 1.01: Entry into a Material Definitive AgreementItem 3.02: Unregistered Sales of Equity SecuritiesItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接